Literature DB >> 21214520

Dendritic cells in networks of immunological tolerance.

S Gregori1.   

Abstract

Dendritic cells (DC) represent pacemakers of the immune system because they play a major role as antigen-presenting cells in inducing adaptive immune responses on the one hand and are critically involved in promoting and maintaining immunological tolerance on the other. The latter function is mediated by specialized subsets of DC, named tolerogenic DC, as well as by DC activated or differentiated in the presence of specific biological or chemical agents. Suppression by tolerogenic DC is primarily mediated via the induction of regulatory T (Tr) cells. In the present review, we will focus on human tolerogenic DC with the aim to: (1) describe subsets of human tolerogenic DC; (2) define the modes of in vitro induction of myeloid tolerogenic DC and their ability to induce Tr cells; (3) elucidate the role of tolerogenic DC in orchestrating tolerance induction in vivo; and (4) envisage the use of tolerogenic DC as therapeutic tool to trigger immunoregulatory mechanisms.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2011        PMID: 21214520     DOI: 10.1111/j.1399-0039.2010.01615.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  23 in total

1.  Leptin and ghrelin regulate dendritic cell maturation and dendritic cell induction of regulatory T-cells.

Authors:  E G Orlova; S V Shirshev; O A Loginova
Journal:  Dokl Biol Sci       Date:  2015-07-12

2.  Immunosuppressive mechanisms of regulatory dendritic cells in cancer.

Authors:  Galina V Shurin; Yang Ma; Michael R Shurin
Journal:  Cancer Microenviron       Date:  2013-06-09

3.  Leukotriene C(4) prevents the complete maturation of murine dendritic cells and modifies interleukin-12/interleukin-23 balance.

Authors:  Carolina Alvarez; María M Amaral; Cecilia Langellotti; Mónica Vermeulen
Journal:  Immunology       Date:  2011-10       Impact factor: 7.397

Review 4.  Dendritic cells as therapeutic targets in neuroinflammation.

Authors:  Felix Luessi; Frauke Zipp; Esther Witsch
Journal:  Cell Mol Life Sci       Date:  2016-03-12       Impact factor: 9.261

5.  Dendritic cells phenotype fitting under hypoxia or lipopolysaccharide; adenosine 5'-triphosphate-binding cassette transporters far beyond an efflux pump.

Authors:  N Lloberas; I Rama; I Llaudó; J Torras; G Cerezo; L Cassis; M Franquesa; A Merino; D Benitez-Ribas; J M Cruzado; I Herrero-Fresneda; O Bestard; J M Grinyó
Journal:  Clin Exp Immunol       Date:  2013-06       Impact factor: 4.330

6.  Age-related patterns in human myeloid dendritic cell populations in people exposed to Schistosoma haematobium infection.

Authors:  Norman Nausch; Delphine Louis; Olivier Lantz; Isabelle Peguillet; François Trottein; Isobel Y D Chen; Laura J Appleby; Claire D Bourke; Nicholas Midzi; Takafira Mduluza; Francisca Mutapi
Journal:  PLoS Negl Trop Dis       Date:  2012-09-27

7.  Bovine lactoferrin counteracts Toll-like receptor mediated activation signals in antigen presenting cells.

Authors:  Patrizia Puddu; Daniela Latorre; Maria Carollo; Angela Catizone; Giulia Ricci; Piera Valenti; Sandra Gessani
Journal:  PLoS One       Date:  2011-07-25       Impact factor: 3.240

8.  Neuroantigen-specific, tolerogenic vaccines: GM-CSF is a fusion partner that facilitates tolerance rather than immunity to dominant self-epitopes of myelin in murine models of experimental autoimmune encephalomyelitis (EAE).

Authors:  Derek J Abbott; J Lori Blanchfield; David A Martinson; Sean C Russell; Najla Taslim; Alan D Curtis; Mark D Mannie
Journal:  BMC Immunol       Date:  2011-12-30       Impact factor: 3.615

9.  Human tolerogenic DC-10: perspectives for clinical applications.

Authors:  Giada Amodio; Silvia Gregori
Journal:  Transplant Res       Date:  2012-09-28

10.  Dendritic cells a double-edge sword in autoimmune responses.

Authors:  Giada Amodio; Silvia Gregori
Journal:  Front Immunol       Date:  2012-08-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.